Perifosine Mechanisms of Action in Leishmania Species

Atteneri López-Arencibia1,2, Carmen Martín-Navarro2, Ines Sifaoui3

  • 1Centre for Integrative Physiology, Biomedical Sciences, Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom atlopez@ull.edu.es.

Insights

Perifosine induces cell death in Leishmania parasites by disrupting mitochondrial function and inhibiting Akt phosphorylation. This suggests perifosine as a potential alternative treatment for leishmaniasis.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Drug Discovery

Background:

  • Leishmaniasis remains a significant global health concern, with limited treatment options.
  • Miltefosine is a key drug for treating leishmaniasis, but resistance is a growing issue.
  • Understanding new drug mechanisms is crucial for developing alternative therapies.

Purpose of the Study:

  • To elucidate the mechanism of cell death induced by perifosine in *Leishmania donovani* and *Leishmania amazonensis*.
  • To investigate the effects of perifosine on parasite mitochondrial function and key signaling pathways.
  • To assess the potential of perifosine as an alternative to miltefosine.

Main Methods:

  • Measurement of mitochondrial membrane potential in *Leishmania*.
  • Quantification of cellular ATP levels.
  • Assay for phosphatidylserine externalization.
  • Analysis of Akt phosphorylation in response to perifosine treatment.

Main Results:

  • Perifosine significantly reduced mitochondrial membrane potential in *Leishmania* species.
  • A decrease in cellular ATP levels and an increase in phosphatidylserine externalization were observed.
  • Perifosine did not induce membrane permeabilization.
  • Inhibition of Akt phosphorylation was confirmed in the treated parasites.

Conclusions:

  • Perifosine triggers cell death in *Leishmania* through mitochondrial dysfunction and inhibition of Akt signaling.
  • The drug's mechanism differs from membrane permeabilization, suggesting a distinct mode of action.
  • Perifosine shows promise as a potential alternative therapeutic agent for leishmaniasis, particularly against miltefosine-resistant strains.